HCA Healthcare, Inc. (HCA) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
HCA Revenue Growth
Revenue Breakdown (FY 2025)
HCA's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
HCA Revenue Analysis (2014–2025)
As of May 6, 2026, HCA Healthcare, Inc. (HCA) generated trailing twelve-month (TTM) revenue of $75.60 billion, reflecting solid growth of +6.7% year-over-year. The most recent quarter (Q4 2025) recorded $19.51 billion in revenue, up 1.8% sequentially.
Looking at the longer-term picture, HCA's 5-year compound annual growth rate (CAGR) stands at +8.0%, indicating steady revenue expansion. The company achieved its highest annual revenue of $75.60 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows HCA's business is primarily driven by Managed Care And Other Insurers (51%), Managed Medicare (18%), and Medicare (15%). With over half of revenue concentrated in Managed Care And Other Insurers, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including THC (+4.6% YoY), CYH (+69.8% YoY), and UHS (+10.4% YoY), HCA has underperformed the peer group in terms of revenue growth. Compare HCA vs THC →
HCA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HCACurrent | $75.6B | +6.7% | +8.0% | 15.8% | |
 THC | $21.3B | +4.6% | +3.9% | 16.1% | |
 CYH | $12.5B | +69.8% | +1.2% | -79.4% | |
 UHS | $17.4B | +10.4% | +8.5% | 11.5% | |
 ENSG | $5.1B | +19.2% | +16.1% | 8.6% | |
 SEM | $5.5B | +29.2% | -0.3% | 6.1% |
HCA Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $75.60B | +7.1% | $31.37B | 41.5% | $11.96B | 15.8% |
| 2024 | $70.60B | +8.7% | $28.68B | 40.6% | $10.55B | 14.9% |
| 2023 | $64.97B | +7.9% | $25.58B | 39.4% | $9.63B | 14.8% |
| 2022 | $60.23B | +2.5% | $23.18B | 38.5% | $9.05B | 15.0% |
| 2021 | $58.75B | +14.0% | $22.49B | 38.3% | $9.68B | 16.5% |
| 2020 | $51.53B | +0.4% | $43.16B | 83.8% | $7.26B | 14.1% |
| 2019 | $51.34B | +10.0% | $42.85B | 83.5% | $7.22B | 14.1% |
| 2018 | $46.68B | +7.0% | $38.95B | 83.5% | $6.64B | 14.2% |
| 2017 | $43.61B | +5.1% | $36.30B | 83.2% | $6.06B | 13.9% |
| 2016 | $41.49B | +4.6% | $34.56B | 83.3% | $6.20B | 14.9% |
Full HCA Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See HCA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HCA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HCA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHCA — Frequently Asked Questions
Quick answers to the most common questions about buying HCA stock.
Is HCA's revenue growth accelerating or slowing?
HCA maintains +6.7% revenue growth, in line with its 5-year CAGR of +8.0%. TTM revenue stands at $75.6B. Growth rate remains consistent with historical average.
What is HCA's long-term revenue growth rate?
HCA Healthcare, Inc.'s 5-year revenue CAGR of +8.0% reflects the sustained expansion pattern. Current YoY growth of +6.7% is near this long-term average.
How is HCA's revenue distributed by segment?
HCA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.